• 1. Fate of Sb(v) and Sb(iii) species along a gradient of pH and oxygen concentration in the Carnoulès mine waters (Southern France)
  Eléonore Resongles,Corinne Casiot,Fran?oise Elbaz-Poulichet,Rémi Freydier,Odile Bruneel,Christine Piot,Sophie Delpoux,Aurélie Volant,Angélique Desoeuvre Environ. Sci.: Processes Impacts, 2013,15, 1536-1544
• 2. Fate of nitrogen-15 in the subsequent growing season of greenhouse tomato plants (Lycopersicon esculentum Mill) as influenced by alternate partial root-zone irrigation
  Maomao Hou,Fenglin Zhong,Qiu Jin,Enjiang Liu,Jie Feng,Tengyun Wang,Yue Gao RSC Adv., 2017,7, 34392-34400
• 3. Enabling shape memory and healable effects in a conjugated polymer by incorporating siloxane via dynamic imine bond?
  Yaling Zhang,Chunhui Dai,Shiwei Zhou,Bin Liu Chem. Commun., 2018,54, 10092-10095
• 4. Emulsion technologies for multicellular tumour spheroid radiation assays?
  Kay S. McMillan,Anthony G. McCluskey,Annette Sorensen,Marie Boyd,Michele Zagnoni Analyst, 2016,141, 100-110
• 5. Evolution of cellulose into flexible conductive green electronics: a smart strategy to fabricate sustainable electrodes for supercapacitors
  Tengfei Yu,Yuehan Wu,Wei Li,Bin Li RSC Adv., 2014,4, 34134-34143

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Quinolines and derivatives Hydroquinolones
• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Quinolines and derivatives Quinolones and derivatives Hydroquinolones

Introduction to 4,6-Dimethylquinolin-2(1H)-one (CAS No. 23947-37-7)

4,6-Dimethylquinolin-2(1H)-one, identified by its Chemical Abstracts Service (CAS) number 23947-37-7, is a heterocyclic organic compound that has garnered significant attention in the field of chemical biology and pharmaceutical research. This compound belongs to the quinoline family, a class of molecules known for their diverse biological activities and applications in medicinal chemistry. The structural framework of 4,6-Dimethylquinolin-2(1H)-one features a quinoline core with methyl substituents at the 4- and 6-positions, and a carbonyl group at the 2-position, which contributes to its unique chemical properties and reactivity.

The quinoline scaffold has a long history in medicinal chemistry, with numerous derivatives exhibiting antimicrobial, antimalarial, anti-inflammatory, and anticancer properties. Among these derivatives, 4,6-Dimethylquinolin-2(1H)-one has emerged as a compound of interest due to its potential pharmacological effects. Recent studies have highlighted its role as a versatile intermediate in the synthesis of more complex bioactive molecules, particularly in the development of small-molecule inhibitors targeting specific biological pathways.

One of the most compelling aspects of 4,6-Dimethylquinolin-2(1H)-one is its structural flexibility, which allows for further functionalization to tailor its biological activity. Researchers have explored various modifications to the quinoline core, including the introduction of additional substituents or heterocycles, to enhance binding affinity and selectivity. These modifications have led to the discovery of novel compounds with improved pharmacokinetic profiles and reduced toxicity.

In recent years, 4,6-Dimethylquinolin-2(1H)-one has been investigated for its potential applications in oncology. Preclinical studies have demonstrated that derivatives of this compound can interfere with key signaling pathways involved in cancer cell proliferation and survival. For instance, certain analogs have shown promise in inhibiting tyrosine kinases, which are often overexpressed in tumor cells and contribute to uncontrolled growth. The ability of 4,6-Dimethylquinolin-2(1H)-one to modulate these pathways makes it a valuable scaffold for developing next-generation anticancer agents.

Another area where 4,6-Dimethylquinolin-2(1H)-one has shown promise is in antimicrobial research. The quinoline moiety is well-known for its activity against a range of pathogens, including bacteria and viruses. By incorporating methyl groups at the 4- and 6-positions, researchers have been able to enhance the compound's efficacy against resistant strains. This has opened up new avenues for the development of antimicrobial therapies that can combat emerging drug-resistant pathogens.

The synthesis of 4,6-Dimethylquinolin-2(1H)-one typically involves multi-step organic reactions starting from readily available precursors. Common synthetic routes include cyclization reactions followed by functional group transformations to introduce the desired substituents. Advances in synthetic methodologies have enabled more efficient and scalable production processes, making it feasible to explore its applications on a larger scale.

From a chemical biology perspective, 4,6-Dimethylquinolin-2(1H)-one serves as an excellent tool for studying enzyme inhibition and receptor binding. Its structural features allow it to interact with various biological targets, providing insights into molecular recognition processes. This has been particularly useful in drug discovery efforts aimed at identifying lead compounds for further optimization.

The pharmacological profile of 4,6-Dimethylquinolin-2(1H)-one is further enhanced by its ability to cross biological membranes due to its lipophilic nature. This property is crucial for compounds intended for systemic administration, as it ensures adequate absorption and distribution within the body. Additionally, studies have indicated that modifications to the quinoline core can influence metabolic stability and excretion rates, which are critical factors in determining a drug's overall efficacy.

In conclusion,4,6-Dimethylquinolin-2(1H)-one (CAS No. 23947-37-7) represents a promising compound with diverse applications in pharmaceutical research. Its unique structural features make it a versatile scaffold for developing bioactive molecules targeting various diseases. As research continues to uncover new therapeutic possibilities,4,6-Dimethylquinolin-2(1H)-one is poised to play an increasingly important role in the discovery and development of novel treatments.

• 607-66-9(2-Hydroxy-4-methylquinoline)
• 19840-99-4(Carbostyril 124)
• 19841-02-2(7-amino-4-phenylquinolin-2(1H)-one)
• 26078-23-9(2(1H)-Quinolinone,7-(dimethylamino)-4-methyl-)
• 42414-28-8(4,6,8-trimethyl-1,2-dihydroquinolin-2-one)
• 53761-44-7(2(1H)-Quinolinone, 8-ethyl-4-methyl-)
• 5855-57-2(4-phenylquinolin-2-ol)
• 2585-18-4(4,7-Dimethylquinolin-2(1H)-one)
• 5349-78-0(4,8-Dimethylquinolin-2(1H)-one)
• 51592-38-2(6-Ethyl-4-methylquinolin-2(1H)-one)